Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002069456 | SCV002442730 | likely benign | not provided | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004035486 | SCV004963592 | uncertain significance | Inborn genetic diseases | 2022-12-19 | criteria provided, single submitter | clinical testing | The c.1487C>T (p.T496M) alteration is located in exon 13 (coding exon 12) of the TCIRG1 gene. This alteration results from a C to T substitution at nucleotide position 1487, causing the threonine (T) at amino acid position 496 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV002069456 | SCV005218215 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001279340 | SCV001466428 | uncertain significance | Autosomal recessive osteopetrosis 1 | 2020-04-16 | no assertion criteria provided | clinical testing |